Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Metoprolol succinate 25mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoprolol succinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metoprolol succinate 100mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoprolol succinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metoprolol succinate 50mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoprolol succinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metoprolol succinate 200mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoprolol succinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adverse reaction caused by metoprolol succinate (disorder) |
Causative agent (attribute) |
True |
Metoprolol succinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metoprolol succinate 200mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoprolol succinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metoprolol succinate 100mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoprolol succinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metoprolol succinate 25mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoprolol succinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metoprolol succinate 50mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoprolol succinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metoprolol tartrate (as metoprolol succinate) 25 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Metoprolol succinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metoprolol tartrate (as metoprolol succinate) 50 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Metoprolol succinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metoprolol tartrate (as metoprolol succinate) 100 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Metoprolol succinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metoprolol tartrate (as metoprolol succinate) 200 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Metoprolol succinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metoprolol tartrate (as metoprolol succinate) 12.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Metoprolol succinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Metoprolol succinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amlodipine (as amlodipine besilate) 5 mg and metoprolol tartrate (as metoprolol succinate) 50 mg conventional release and prolonged-release oral tablet |
Has precise active ingredient |
True |
Metoprolol succinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amlodipine (as amlodipine besilate) 5 mg and metoprolol tartrate (as metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet |
Has precise active ingredient |
True |
Metoprolol succinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amlodipine (as amlodipine besilate) 2.5 mg and metoprolol tartrate (as metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet |
Has precise active ingredient |
True |
Metoprolol succinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |